Guillermina Remaggi

5PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMedical mycologyImmunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 09, 2026
Long-term follow-up of PET/CT-adapted therapy after three cycles of ABVD for all stages of classic Hodgkin lymphoma: Results of the GATLA LH-05 trial.

|Dec 10, 2024
Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study.

Vania Hungria, Rafael Gaiolla, Kenny Galvez

|Dec 07, 2023
Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America.

Humberto Martínez-Cordero, Camila Peña, Natalia Paola Schutz

|Aug 08, 2022
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study.

Eloísa Riva, Patricio José Duarte, Bryan Valcárcel

|Jul 14, 2022
Selinexor in Patients from Argentina with Multiple Myeloma Treated with Multiple Prior Therapies: A Case Series.

Guillermina Remaggi, Paola A Ochoa, Gonzalo M Garate

Pageof 1

Frequent Collaborators

2 joint publications

Eloísa Riva

2 joint publications

Guillermo Quintero-Vega

2 joint publications

Natalia Schutz

2 joint publications

Camila Peña